Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 7/2003

01-11-2003

Expression of the 67 kDa laminin receptor and the α6 integrin subunit in serous ovarian carcinoma

Authors: Vered Givant-Horwitz, Ben Davidson, Gregg van de Putte, Hiep Phuc Dong, Iris Goldberg, Sivan Amir, Gunnar B. Kristensen, Reuven Reich

Published in: Clinical & Experimental Metastasis | Issue 7/2003

Login to get access
Metadata
Title
Expression of the 67 kDa laminin receptor and the α6 integrin subunit in serous ovarian carcinoma
Authors
Vered Givant-Horwitz
Ben Davidson
Gregg van de Putte
Hiep Phuc Dong
Iris Goldberg
Sivan Amir
Gunnar B. Kristensen
Reuven Reich
Publication date
01-11-2003
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 7/2003
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1027340208536

Other articles of this Issue 7/2003

Clinical & Experimental Metastasis 7/2003 Go to the issue

OriginalPaper

Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): Co-expression in metastatic serous ovarian carcinoma

OriginalPaper

Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase

OriginalPaper

Biological properties and gene expression associated with metastatic potential of human osteosarcoma

OriginalPaper

Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells

OriginalPaper

Suppression of pancreatic cancer cell invasion by a cyclooxygenase-2-specific inhibitor

OriginalPaper

Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits